BA
CLLS

BlackRock Advisors’s Cellectis CLLS Stock Holding History

BlackRock Advisors’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-93,586
Closed -$2.9M – 3772
2015
Q4 		$2.9M Sell
93,586
-249,723
-73% -$7.58M ﹤0.01% 1272
2015
Q3 		$9.05M Buy
343,309
+38,683
+13% +$1.29M 0.01% 832
2015
Q2 		$11M Buy
304,626
+142,126
+87% +$4.99M 0.01% 724
2015
Q1 		$5.62M Buy
+162,500
New +$5.9M 0.01% 944

Other funds holding CLLS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
THSP
Taube Hodson Stonex Partners London, United Kingdom $488M AUM 4.7% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

BlackRock Advisors's CLLS Position: Q1 2016 in Review

BlackRock Advisors sold out of Cellectis (CLLS) in Q1 2016, closing a stake of 93,586 shares — an estimated $2.9M sold.

BlackRock Advisors first reported a position in CLLS in Q1 2015 and held it in 4 quarters. The position peaked at $11M in Q2 2015. 44 funds tracked by Wall St. Rank hold CLLS as of Q1 2016.

  • BlackRock Advisors reported no remaining Cellectis position as of Q1 2016 after selling out during the quarter.
  • BlackRock Advisors sold 93,586 Cellectis shares in Q1 2016, an estimated $2.9M.
  • BlackRock Advisors first reported a position in Cellectis in Q1 2015 and held it in 4 quarters.
  • BlackRock Advisors's Cellectis position peaked at $11M in Q2 2015.
  • 44 funds tracked by Wall St. Rank held Cellectis as of Q1 2016.

Based on BlackRock Advisors's 13F filing for Q1 2016, filed 10 May 2016.